Objective: The HLA-G molecules are nonclassic class I antigens with anti-inflammatory and tolerogenic properties, while interleukin-17A (IL-17A) is a key inflammatory cytokine in many disorders. Considering that, the aims of this study were: 1) to evaluate the HLA-G molecule, and 2) to evaluate IL-17A expression in patients presenting with nasal polyposis.
Method: Samples of patients presenting with nasal polyposis (n = 20) were subjected to immunohistochemistry technique. All patients were grouped into atopic and nonatopic patients according to skin prick test and IgE dosage. All statistical analyses were performed using the GraphPad Prism 5.0. The level of statistical significance was accepted at P < .05.
Results: Our preliminary results showed the HLA-G and IL-17A expression in nasal polyposis. Immunohistochemical staining demonstrated a higher expression of HLA-G molecule in samples of nonatopic patients when compared with atopic patients (P = .04). The IL-17A expression was also observed in both atopic and nonatopic patients; however, the numbers of IL-17A positive cells were greater in nasal polyps of atopic patients than in those of nonatopic patients.
Conclusion: These preliminary results indicated that HLA-G and IL-17A may play an important role in the pathology of nasal polyposis. Considering the anti-inflammatory properties of HLA-G and inflammatory activities of IL-17A, we suggest that HLA-G could decreased the susceptibility to disease, while IL-17 should be associated with more severe atopy.
General Otolaryngology
The Utility of Facial Nerve Monitoring for Parotid Surgery Christian G. Samuelson, MD (presenter); Michael Friedman, MD; Craig S. Hamilton, MD Objective: To assess the utility of facial nerve monitoring in preventing transient and permanent facial paralysis in patients undergoing parotid surgery.
Method: PubMed, MEDLINE, and Cochrane Trial Registry through December 2011 were searched and combined with manual review of relevant article bibliographies. All studies were assessed by 3 reviewers. Systematic review and random-effects meta-analysis were performed of studies comparing the incidence of facial nerve injury in monitored and unmonitored parotid surgery.
Results: Five studies met inclusion criteria and had data suitable for pooling (374 patients). Overall, monitoring provided no benefit in reduction of facial paralysis with an odds ratio (OR) of 0.754 (0.488, 1.165; P = .203). In addition, sensitivity analysis revealed that neither transient nor permanent facial paralysis is significantly reduced with the use of monitoring. Analysis of publication bias revealed a nonsignificant Egger's regression intercept; however, a single imputed value representing a "missing" study was found to the left of the calculated OR. Addition of this imputed value in no way altered the significance of our findings.
Conclusion: Facial nerve monitoring does not significantly reduce the incidence of transient or permanent facial paralysis in parotid surgery. While few "high-level evidence" studies were available for review, our results were not affected by publication bias. Nerve integrity monitoring should not be considered the standard of care for parotid surgery.
Throat Symptoms: The importance in Peritonsillar Abscess Jason Powell, MBBS, MRCS (presenter); Emily L. Powell; Katherine Conroy, MD; Claire Hopkins, FRCS; James Moor, MD; Janet A. Wilson, MD, FRCS Objective: The incidence of quinsy is rising in the UK for reasons which are unclear. There were >7000 hospital diagnosed episodes last year in England alone. Some suggest a link to the decline in elective tonsillectomy. Our aim was to compare chronic throat symptoms in quinsy patients and controls.
Method: The validated 16-item Tonsillectomy Outcome Inventory (TOI-16) was used to compare the impact of throat symptoms over the previous 6 months in 119 controls (no quinsy history) and 55 contactable (by telephone) quinsy patients (34M, 21F), who had an average experience of 1.4 (range 0-4) quinsies. Analysis was in SPSS.
Results: The TOI-16 Cronbach's α = .92, indicating high internal consistency. The mean 6-month overall throat impact scores in quinsy patients (21.0) were significantly greater than that in volunteers (10.9 P < .05). The post-quinsy interval had only modest effect on the overall mean score. Younger people had higher scores in both groups. On item-by-item analysis, quinsy patients recorded significantly higher mean reported scores over the previous 6 months for snoring, visits to the doctor, and frequent use of antibiotics (all P < .001) and halitosis, catarrh, missed social gatherings or events, missed work-days, and depression due to throat problems (all P < .05).
Conclusion:
Ongoing throat problems are far more prevalent and severe in quinsy patients than controls, with a clear life impact. In many, quinsy represents an acute episode on a background of chronic throat problems. The optimal acute management-notably the place and timing of tonsillectomyshould take account of this.
